Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
KLA Corp a un objectif de cours consensus de $921.74, basé sur les évaluations des 23 analystes. Le plus élevé est de $1200 attribué par Barclays le octobre 20, 2025, et le plus bas est de $655 attribué par Susquehanna le janvier 22, 2025. Les 3 dernières évaluations d'analystes ont été publiées par UBS, Barclays et Stifel le octobre 20, 2025, octobre 20, 2025 et octobre 13, 2025. Avec un objectif de cours moyen de $1128.33 entre UBS, Barclays et Stifel, il y a une variation implicite de -4.86% downside pour KLA Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
Barclays
Stifel
Goldman Sachs
Morgan Stanley
1calculé à partir des notes des analystes
Notes d'analystes pour KLA
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/20/2025 | -4.3% | UBS | $970 → $1135 | Maintains | Neutral | |||
10/20/2025 | 1.18% | Barclays | $750 → $1200 | Upgrade | Equal-Weight → Overweight | |||
10/13/2025 | -11.47% | Stifel | $922 → $1050 | Maintains | Buy | |||
10/09/2025 | -5.57% | Goldman Sachs | $980 → $1120 | Maintains | Neutral | |||
09/22/2025 | -7.84% | Morgan Stanley | $928 → $1093 | Downgrade | Overweight → Equal-Weight | |||
08/01/2025 | -10.63% | Citigroup | $1035 → $1060 | Maintains | Buy | |||
08/01/2025 | -22.26% | Stifel | $770 → $922 | Maintains | Buy | |||
08/01/2025 | -9.78% | JP Morgan | $900 → $1070 | Maintains | Overweight | |||
08/01/2025 | -19.9% | Raymond James | $850 → $950 | Reiterates | Outperform → Outperform | |||
08/01/2025 | -21.75% | Morgan Stanley | $916 → $928 | Maintains | Overweight | |||
07/28/2025 | -36.76% | Barclays | $590 → $750 | Maintains | Equal-Weight | |||
07/21/2025 | -19.06% | UBS | $775 → $960 | Maintains | Neutral | |||
07/10/2025 | -17.37% | Goldman Sachs | → $980 | Initiates | → Neutral | |||
07/08/2025 | -22.43% | Wells Fargo | $870 → $920 | Downgrade | Overweight → Equal-Weight | |||
07/07/2025 | -12.73% | Citigroup | $835 → $1035 | Maintains | Buy | |||
07/01/2025 | -22.77% | Morgan Stanley | $868 → $916 | Maintains | Overweight | |||
06/24/2025 | -19.9% | Cantor Fitzgerald | $800 → $950 | Maintains | Neutral | |||
06/17/2025 | -19.9% | Oppenheimer | $740 → $950 | Maintains | Outperform | |||
05/01/2025 | -24.12% | JP Morgan | $950 → $900 | Maintains | Overweight | |||
05/01/2025 | -26.81% | Morgan Stanley | $870 → $868 | Maintains | Overweight | |||
05/01/2025 | -32.55% | Cantor Fitzgerald | $800 → $800 | Maintains | Neutral | |||
05/01/2025 | -35.08% | Stifel | $750 → $770 | Maintains | Buy | |||
05/01/2025 | -32.55% | TD Securities | $770 → $800 | Maintains | Hold | |||
05/01/2025 | -37.61% | Oppenheimer | $700 → $740 | Maintains | Outperform | |||
05/01/2025 | -37.61% | UBS | $690 → $740 | Maintains | Neutral | |||
05/01/2025 | -30.02% | Needham | $830 → $830 | Reiterates | Buy → Buy | |||
04/22/2025 | -50.25% | Barclays | $760 → $590 | Maintains | Equal-Weight | |||
04/16/2025 | -32.13% | B of A Securities | $900 → $805 | Maintains | Buy | |||
04/15/2025 | -36.76% | Stifel | $825 → $750 | Maintains | Buy | |||
04/11/2025 | -32.55% | Citigroup | $910 → $800 | Maintains | Buy | |||
04/11/2025 | -40.98% | Oppenheimer | $850 → $700 | Maintains | Outperform | |||
03/31/2025 | -26.65% | Morgan Stanley | $748 → $870 | Upgrade | Equal-Weight → Overweight | |||
03/28/2025 | -38.87% | Jefferies | → $725 | Downgrade | Buy → Hold | |||
02/03/2025 | -36.93% | Morgan Stanley | $703 → $748 | Maintains | Equal-Weight | |||
01/31/2025 | -27.15% | Goldman Sachs | $759 → $864 | Maintains | Buy | |||
01/31/2025 | -30.44% | Stifel | $800 → $825 | Maintains | Buy | |||
01/31/2025 | -26.65% | Wells Fargo | $795 → $870 | Maintains | Overweight | |||
01/31/2025 | -26.22% | Cantor Fitzgerald | $800 → $875 | Maintains | Neutral | |||
01/31/2025 | -35.92% | Barclays | $700 → $760 | Maintains | Equal-Weight | |||
01/31/2025 | -30.02% | Needham | $800 → $830 | Maintains | Buy | |||
01/31/2025 | -28.33% | Deutsche Bank | $725 → $850 | Maintains | Buy | |||
01/22/2025 | -44.77% | Susquehanna | $620 → $655 | Maintains | Neutral | |||
01/21/2025 | -34.23% | UBS | $665 → $780 | Maintains | Neutral | |||
01/17/2025 | -40.98% | Barclays | $750 → $700 | Maintains | Equal-Weight | |||
01/13/2025 | -32.97% | Wells Fargo | $800 → $795 | Maintains | Overweight | |||
01/10/2025 | -36% | Goldman Sachs | $850 → $759 | Maintains | Buy | |||
12/06/2024 | -32.55% | Wells Fargo | $870 → $800 | Maintains | Overweight | |||
12/05/2024 | -40.73% | Morgan Stanley | $746 → $703 | Maintains | Equal-Weight | |||
10/31/2024 | -38.87% | TD Cowen | $760 → $725 | Maintains | Hold | |||
10/31/2024 | -36.76% | Barclays | $800 → $750 | Maintains | Equal-Weight | |||
10/31/2024 | — | Needham | — | Reiterates | → Hold | |||
10/31/2024 | -28.33% | Oppenheimer | $750 → $850 | Upgrade | Perform → Outperform | |||
10/31/2024 | -36.76% | Deutsche Bank | $890 → $750 | Maintains | Buy | |||
10/11/2024 | -43.09% | Susquehanna | $680 → $675 | Maintains | Neutral | |||
10/08/2024 | -22.01% | Cantor Fitzgerald | $925 → $925 | Reiterates | Neutral → Neutral | |||
10/03/2024 | -26.65% | Wells Fargo | $950 → $870 | Maintains | Overweight | |||
09/30/2024 | -22.01% | Cantor Fitzgerald | $950 → $925 | Maintains | Neutral | |||
09/25/2024 | -36.76% | Oppenheimer | → $750 | Initiates | → Perform | |||
09/16/2024 | -24.12% | Citigroup | $960 → $900 | Maintains | Buy | |||
09/12/2024 | -35.5% | UBS | $900 → $765 | Maintains | Neutral | |||
08/05/2024 | -19.06% | Citigroup | $990 → $960 | Maintains | Buy | |||
07/26/2024 | -26.22% | Argus Research | $800 → $875 | Maintains | Buy | |||
07/25/2024 | -35.92% | TD Cowen | $700 → $760 | Maintains | Hold | |||
07/25/2024 | -24.12% | Evercore ISI Group | $800 → $900 | Maintains | Outperform | |||
07/25/2024 | -29.34% | Goldman Sachs | $735 → $838 | Maintains | Buy | |||
07/25/2024 | -19.9% | Cantor Fitzgerald | $950 → $950 | Reiterates | Neutral → Neutral | |||
07/25/2024 | -19.9% | JP Morgan | $800 → $950 | Maintains | Overweight | |||
07/25/2024 | -32.55% | Barclays | $765 → $800 | Maintains | Equal-Weight | |||
07/25/2024 | -42.67% | Susquehanna | $730 → $680 | Maintains | Neutral | |||
07/16/2024 | -19.9% | Cantor Fitzgerald | $800 → $950 | Maintains | Neutral | |||
07/16/2024 | -26.22% | Stifel | $760 → $875 | Maintains | Buy | |||
07/15/2024 | -17.37% | Citigroup | $760 → $980 | Maintains | Buy | |||
06/17/2024 | -19.9% | Wells Fargo | $860 → $950 | Maintains | Overweight | |||
06/07/2024 | -26.22% | Raymond James | $750 → $875 | Maintains | Outperform | |||
06/05/2024 | -35.5% | Barclays | $630 → $765 | Upgrade | Underweight → Equal-Weight | |||
05/13/2024 | -30.86% | Jefferies | $740 → $820 | Assumes | Buy → Buy | |||
04/29/2024 | -35.92% | Citigroup | $725 → $760 | Maintains | Buy | |||
04/26/2024 | -32.55% | JP Morgan | $725 → $800 | Maintains | Overweight | |||
04/26/2024 | -40.98% | TD Cowen | $650 → $700 | Maintains | Hold | |||
04/26/2024 | -36.76% | Raymond James | $625 → $750 | Reiterates | Outperform → Outperform | |||
04/26/2024 | -41.15% | Morgan Stanley | $692 → $698 | Maintains | Equal-Weight | |||
04/26/2024 | -46.88% | Barclays | $550 → $630 | Maintains | Underweight | |||
04/26/2024 | — | Needham | — | Reiterates | → Hold | |||
04/23/2024 | -38.87% | Citigroup | $700 → $725 | Maintains | Buy | |||
04/16/2024 | -35.92% | Stifel | $685 → $760 | Maintains | Buy | |||
04/16/2024 | -32.55% | Evercore ISI Group | → $800 | Initiates | → Outperform | |||
04/08/2024 | -32.55% | Cantor Fitzgerald | $625 → $800 | Maintains | Neutral | |||
04/02/2024 | -32.13% | Wells Fargo | $760 → $805 | Maintains | Overweight | |||
04/01/2024 | -43.09% | Susquehanna | $675 → $675 | Maintains | Neutral | |||
03/25/2024 | -42.24% | Stifel | → $685 | Reiterates | Buy → Buy | |||
03/19/2024 | -35.92% | Wells Fargo | $750 → $760 | Maintains | Overweight | |||
03/14/2024 | -28.33% | B of A Securities | $740 → $850 | Maintains | Buy | |||
03/11/2024 | -47.3% | Cantor Fitzgerald | $625 → $625 | Reiterates | Neutral → Neutral | |||
03/05/2024 | -35.92% | UBS | $605 → $760 | Maintains | Neutral | |||
03/04/2024 | -47.3% | Cantor Fitzgerald | $625 → $625 | Reiterates | Neutral → Neutral | |||
02/20/2024 | -47.3% | Cantor Fitzgerald | $625 → $625 | Reiterates | Neutral → Neutral | |||
02/12/2024 | -47.3% | Cantor Fitzgerald | $625 → $625 | Reiterates | Neutral → Neutral | |||
01/29/2024 | -47.3% | Cantor Fitzgerald | $625 → $625 | Reiterates | Neutral → Neutral | |||
01/29/2024 | -46.04% | Goldman Sachs | $560 → $640 | Maintains | Buy | |||
01/29/2024 | -43.09% | Susquehanna | $640 → $675 | Downgrade | Positive → Neutral |
FAQ
Quel est le cours indicatif de l'action KLA (KLAC) ?
Le dernier objectif de prix pour KLA (NASDAQ:KLAC) a été rapporté par UBS le octobre 20, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $1135.00 s'attendant à ce que KLAC se fall dans les 12 prochains mois (un possible changement de -4.30% downside). 53 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour KLA (KLAC) ?
La dernière note d'analyste pour KLA (NASDAQ:KLAC) a été fournie par UBS, et KLA maintenu leur note neutral.
Quand a eu lieu la dernière mise à niveau pour KLA (KLAC) ?
La dernière amélioration pour KLA Corp a eu lieu le octobre 20, 2025 lorsque Barclays a augmenté leur objectif de prix à $1200. Barclays avait précédemment an equal-weight pour KLA Corp.
Quand a eu lieu la dernière dégradation pour KLA (KLAC) ?
La dernière réduction pour KLA Corp a eu lieu le septembre 22, 2025 lorsque Morgan Stanley a changé leur objectif de prix de $928 à $1093 pour KLA Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour KLA (KLAC) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de KLA, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour KLA a été déposée le octobre 20, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 20, 2026.
La note d'analyste pour KLA (KLAC) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de KLA (KLAC) était un maintenu avec un objectif de prix de $970.00 à $1135.00. Le prix actuel de KLA (KLAC) est de $1186.02, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.